Tag Archives: ajan reginald

Just days after the Cardiff-based cell therapy company Cell Therapy Ltd (CTL) signed an agreement with Japan’s Daiichi Sankyo, providing them with the rights to its heart failure drug Heartcel, the company’s chief executive, Ajan Reginald, got interviewed by one of the leading dailies. Heartcel, an immune-modulator progenitor (iMP), can be considered as one of …

Continue reading “Celixir’s CEO discuss about his agreement with the Japanese firm to distribute its heart failure drug”